Skip to content

DR. BENEDIKT SIMOENS

Active
Private limited companyfounded 2013active for 13 yearsKuipersstraat 20, 8000 Brugge, BelgiumKBO/BCE: BE 0526.915.282
Summary

DR. BENEDIKT SIMOENS has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €679,646 and a net result of €189,821. Equity has been growing by about 17% per year since 2019. Its solvency ranks better than 80% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 12-04-2013 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.218.319.427 8000 Brugge, since 12-04-2013
Financial year end
31 March
Peppol
Reachable since 10-01-2026

Board and ownership

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2025
Gross margin
€270,996
▲ 2.1%
Turnover
≈ €420,000
estimated
Profit
€189,821
▲ 4.6%
Equity
€679,646
▼ 7.8%
Total assets
€777,954
▼ 1.0%
  • 2026 accounts not filed, 3 days past the deadline
Score breakdownraises riskFigures for financial year 2025 (filed on 07-11-2025)lowers riskLiquidity: current ratio 7.77, cash €511,894Sector: Human health activities (NACE 86)Equity €679,646 (87.4% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 87.4% of total assets
Liquidity 98-2
short-term debt 12.6% · cash 65.8%
Profitability 99+1
return on assets 24.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025highest value 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 7.77 (15.55 in 2024), above the usual 1.5. Short-term debt is 12.6% and cash 65.8% of total assets. 12.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 88% on liquidity, 60% on profitability and 28% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 7.77, cash €511,894
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2025 (filed on 07-11-2025)
NBB · annual accounts
lowers risk · Equity €679,646 (87.4% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 7 days late
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 07-11-2025, 7 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
7 days late
2024
on the day
2023
on the day
2022
3 days late
2021
3 days late
2020
11 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 4 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 87% of companies in human healthsector median €124,634 · 20,708 companies €679,646 View
  • Positive: 7 profitable years in a rowprofit 2025: €189,821 7 years View

Recent changes

  1. · Gazette deed Change of role: SIMOENS Benedikt Clement Emile, from manager to director
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as DR. BENEDIKT SIMOENS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €726,000 and €883,000, founded between 2011 and 2014.

CompanyTotal assetsGross margin
DR. BENEDIKT SIMOENS Brugge€777,954€270,996
Dokter Karel Vergauwe Torhout€786,547€279,070
Dokterspraktijk Christophe Verrue Alveringem€758,524€241,648
HUISARTSEN VANDEVELDE EN KIMPE Brugge€883,317€289,619
DR. PAUL DEGRANDE Alveringem€761,073€253,691
DOKTERS KLUIJTMANS-HEYRMAN Schilde€726,018€268,810
Centre de Médecine Héraclès Binche€746,647€252,578
Full comparison

Key facts about DR. BENEDIKT SIMOENS

What is the company number of DR. BENEDIKT SIMOENS?
The company number of DR. BENEDIKT SIMOENS is 0526.915.282. The VAT number is the same number with BE in front: BE 0526.915.282.
Where is DR. BENEDIKT SIMOENS based?
The registered office is at Kuipersstraat 20, 8000 Brugge.Company details
What does DR. BENEDIKT SIMOENS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. BENEDIKT SIMOENS?
The legal form of DR. BENEDIKT SIMOENS is Private limited company (BV).
When was DR. BENEDIKT SIMOENS founded?
DR. BENEDIKT SIMOENS was founded on 12-04-2013.
Is DR. BENEDIKT SIMOENS still active?
Yes, DR. BENEDIKT SIMOENS is an active enterprise in the KBO register.
What is the turnover of DR. BENEDIKT SIMOENS?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €270,996 and 36 comparable companies (NACE 862). It probably lies between €380,000 and €530,000.Financials
Is DR. BENEDIKT SIMOENS profitable?
In financial year 2025, DR. BENEDIKT SIMOENS made a profit of €189,821.
Where can I find the annual accounts of DR. BENEDIKT SIMOENS?
DR. BENEDIKT SIMOENS filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.